.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Farmers Insurance
Deloitte
Merck
Boehringer Ingelheim
Johnson and Johnson
Chubb
Argus Health
Mallinckrodt
Fish and Richardson

Generated: September 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077856

« Back to Dashboard
NDA 077856 describes CLONAZEPAM, which is a drug marketed by Teva, Sun Pharm Inds Inc, Sandoz, Mylan Pharms Inc, Accord Hlthcare, Mylan, Prinston Inc, Watson Labs, Apotex Inc, Actavis Elizabeth, Par Pharm, and Barr, and is included in fifteen NDAs. It is available from forty-seven suppliers. Additional details are available on the CLONAZEPAM profile page.

The generic ingredient in CLONAZEPAM is clonazepam. There are ten drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the clonazepam profile page.

Summary for NDA: 077856

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 077856

Ingredient-typeBenzodiazepines

Suppliers and Packaging for NDA: 077856

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLONAZEPAM
clonazepam
TABLET;ORAL 077856 ANDA Qualitest Pharmaceuticals 0603-2948 0603-2948-02 90 TABLET in 1 BOTTLE, PLASTIC (0603-2948-02)
CLONAZEPAM
clonazepam
TABLET;ORAL 077856 ANDA Qualitest Pharmaceuticals 0603-2948 0603-2948-13 15 TABLET in 1 BOTTLE, PLASTIC (0603-2948-13)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Jun 28, 2006TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Jun 28, 2006TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Jun 28, 2006TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Citi
Covington
AstraZeneca
Mallinckrodt
US Army
Deloitte
Chinese Patent Office
Harvard Business School
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot